Stock News•1 months ago
What's Going On With the Dip in Viking Therapeutics Stock?
Viking Therapeutics shares fell Tuesday amid a broader risk-off session, despite the stock's longer-term uptrend and sector strength remaining intact.
MarketLens
Is Viking Therapeutics Poised to Disrupt the Weight-Loss Market
6 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Category
You may also like
Stock News•3 months ago
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1
Viking Therapeutics started testing a next-gen weight loss drug that targets mechanisms beyond GLP-1, entering a field where Novo Nordisk and Eli Lilly already have advanced programs.
Stock News•3 months ago
Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are Saying
Viking Therapeutics' stock could reach $50 if its weight loss drug succeeds in late-stage trials, targeting a ~$100B market.
Breaking News
View All →Featured Articles
Top Headlines
Stock News•51 minutes ago
Thinking Nvidia Stock Could Hit $10 Trillion? Here's 1 Reason I'd Be Cautious
Stock News•1 hour ago
Nvidia (NVDA) Exceeds Market Returns: Some Facts to Consider
Stock News•1 hour ago
Amazon: Wall Street Is Missing The Bigger Picture
Stock News•1 hour ago
Deadline Alert: Alphabet Inc. Investors Have Until December 1, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds
Stock News•1 hour ago